TALLY BANK A/C NO.

BANK A/C
Sl No Project File No. Name of PI Funding Agency
COMP. NO SB NO. CA

1 112 10074 UBI- 17834 Dr. Ajay Parida DBT-IBSD

2 74 10054 UBI- 17015 Dr. B. Ravindran DBT

3 78 10002 UBI- 17120 Dr. B. Ravindran DBT

4 91 10069 UBI- 17352 Dr. B. Ravindran DBT-BIRAC

5 108 10036 UBI-17816 Dr. B.P. Shaw SERB

6 69 10050 UBI- 35421 Dr. Satish Devadas DBT

7 104 10020 UBI- 17609 Dr. N. Acharya DBT

8 103 10031 UBI- 17783 Dr. N. Acharya SERB

9 80 10003 UBI- 17220 Dr. N. Dey DBT

10 93 10068 UBI-17420 Dr. N. Dey SERB

11 96 10040 Dr. N. Dey DBT- Tata Innovation

12 105 10024 UBI- 17739 Dr. N. Dey SERB

13 75 10056 UBI- 17052 Dr. S. Chakraborty DBT

14 77 10001 UBI- 17106 Dr. Sunil K. Raghav DST ( Indo - Swiss )

15 100 10014 UBI- 17575 Dr. Sunil K. Raghav SERB

16 116 10076 UBI- 17951 Dr. Sunil K. Raghav DBT

17 81 10006 UBI- 17235 Dr. Rupesh Dash DBT-RGCB

18 94 10071 UBI- 17418 Dr. Rupesh Dash SERB

19 82 10008 UBI- 17252 Dr. Rajeeb Swain DBT-RGCB

20 110 10075 UBI- 17835 Dr. Rajeeb Swain SERB

21 106 10026 UBI- 17759 Dr. S. Senapati DBT
22 113 10077 UBI- 17886 Dr. Vivek Rai DBT
23 89 10007 UBI- 17357 Dr. Gulam H. Syed DBT- Welcome Trust

24 115 10078 UBI- 17953 Dr. Gulam H. Syed SERB

25 90 10067 UBI- 17395 Dr. S. Chauhan DBT- Welcome Trust

26 98 10017 UBI- 17576 Dr. S. Chauhan SERB

27 92 10066 UBI- 17394 Dr. Arun Nagaraj DBT-BIRAC

28 95 10072 UBI- 17419 Dr. Arun Nagaraj DBT - CEIB

29 107 10040 Dr. Arun Nagaraj Consultancy Project
30 97 10016 UBI- 17540 Dr. S. Chattopadhyay SERB

31 101 10018 UBI- 17577 Dr. S. Chattopadhyay SERB

32 109 10037 UBI- 17826 Dr. S. Chattopadhyay DBT

33 111 10046 UBI- 17833 Dr. S. Chattopadhyay DBT-IBSD

34 84 10062 UBI - 17276 Dr. Chandana Mohanty DST

35 71 10000 UBI- 17105 Dr. Neera Singh DBT ( Bio care )

36 102 10019 UBI- 17583 Dr. Swati Chauhan DST

37 85 10061 UBI- 17301 Dr. A. Rajkumar Patro SERB

38 114 10080 UBI- 18010 Dr.N.Dey CSIR

39 120 10085 UBI- 18065 Dr.D vasudevan DBT

40 126 10095 UBI- 18198 Dr. N. Dey DBT

41 122 10086 UBI- 18084 Dr.S. Chotapadhyay DBT

42 125 10090 UBI - 18108 Dr.S.K.Das DST-Indo-UK

43 123 10088 UBI- 18106 Dr. Vivek Rai SERB

44 127 10091 UBI- 18199 Dr. Ajay Parida DBT

45 121 10084 UBI- 18078 Dr. Ajay Parida NA SI

46 118 10082 UBI- 18041 Dr. Sagarika Mishra DST

47 117 10087 UBI- 18035 Dr. P. V. Ramachander DST

48 128 10093 UBI- 18133 Dr. T.K. Beuria DBT

49 129 10096 UBI- 18200 Dr. S Chakraborty DBT

50 131 10097 UBI- 18233 Dr. S. Senapati SERB

51 124 10092 UBI- 18107 Dr. S K Mishra Govt of Odisha

52 132 10099 UBI- 18259 A. NAGARAJ SERB

53 134 10100 UBI- 18297 B Ravindran DBT

54 136 10103 UBI- 18412 Dr. Soma Chattopadhyay DBT

55 137 10102 UBI- 18443 Fahima DST - WOS

56 135 10101 UBI - 18326 Dr. Ajay Parida DBT

57 140 10104 UBI - 18499 S SENAPATI DST

58 139 10105 UBI- 18500 AHSAN DST-WOS

UBI- 18523 ( F.Y-

59 138 10106 R SWAIN DBT
2019-20 )
60 130 10094 18232 DV SINGH DBT-ICMR

61 142 10110 UBI - 18538 Dr.Tusharkant Beuria SERB

62 144 10098 UBI- 18571 Dr.Punit Prasad SERB

Dr. Pradeepa under mentorship of

63 X-480-PF SERB- NPDF
Dr.Soumen Chakraborty

Dr.Satyendra Kumar Singh under

64 X-504-PF SERB- NPDF
mentorship of Dr.Vivek Rai

Dr. Trupti Mohapatra under

65 X-533-PF mentorship of Dr. Birendra Prasad SERB- NPDF
Shaw

Dr. Aritreyee Datta under

66 X-467-PF SERB- NPDF
mentorship of Dr.Dileep Vasudevan

Dr.K Vinothkumar under

67 X-469-PF mentorship of Dr.Soumen SERB- NPDF
Chakraborty

Dr.Rashmirekha Pati under

68 X-472-PF SERB- NPDF
mentorship of Dr.Sunil K Raghav

Dr.Shweta Thakur under mentorship

69 X-582-PF SERB- NPDF
of Dr.Narottam Acharya
Title of Project

Partnership programme on Sustainable Bioresources Management

International Associated Laboratory in the area of Systems Immunology and Genetics of
Infectious Diseases (LIA-SIGID)
Reprogramming deleterious inflammatory Monocytes in Human Sepsis
Study to translate CHTX and/or its derivatives for therapeutic intervention in Sepsis
Study of spatio-temporal variation in expression of cell cycle regulators in spikelets of rice
cultivars contrast for panicle compactness and grain filling
Immuno-Pathogenesis of ocular tuberculosis
Understanding role of DNA polymerase eta dependent trans-lesion DNA synthesis in
pathogenicity of Candida albicans

Deciphering the role of DNA polymerase delta dependent mutagenesis induced

morphogenesis, multidrug resistance and pathogenicity of a pathogen C albicans

Studies on interactions of plant transcription factors in promoters from plant infecting

pararetroviruses

Implication of bacteria derived human defensin in burn injury and wound healing
Studies in in vitro interaction between Arabidopsis Transcription factors TGA and WRKY
leading to Salicylic acid mediated gene activation in Cestrum yellow leaf curling virus (CmYLCV)
promoters

Studies on interaction of plant transcription factors in Full length transcript-promoter

fragment of plant infecting Petunia Vein CleaningVirus

Global profiling and significance of alternative splicing events regulated by polypyrimidine

track binding protein 2 (PTBP 2) in the advanced stages of chronic myeloid leukemia

Dissecting co-repressor-centered gene regulatory network underlying dentritic cell immune

responses controlling T helper cell differentiation
Integrative genomics approach to identify the role of zinc finger transcription factors ZEB1 &
ZEB2 in dendritic cells and its impact on T helper cell differentiation
Integrative genomics approach to identify the role of co-regulators in dendritic cell immune
responses and its impact on T helper cell differentiation

Investigating the potential tumor suppressive activity of SARI (Suppressor of AP-1 regulated by
interferon) in Oral Squamous Cell Carcinomas

Restoring cell death in chemoresistant oral squomous cell carcinomas (OSCC)

Tumour Vascular targeting using small molecule inhibitors

Understanding the development and function of kidney using zebrafish

Functional role of MAGEA3- cancer- testis antigen in pancreatic cancer
ATX axis in Satalite Cells and Muscle Repair
Role of Mitochondrial dynamics in Dengue virus life cycle and disease pathogenesis
Unravelling the molecular mechanism(s) underlying Hepatitis C virus morphogenesis and
Secretion
Understanding the role of IRGM-mediated innate immune responses in disease

Determine the mechanism and therapeutic potential of ZKSCAN3- mediated autophagy

An Innovative Algorithm-Based Detection of Identical Multi-Repeat Sequences (IMRS) in the
genome of Plasmodium and its Validation in Malaria Diagnostics
Malarial Parasite Biology: An avenue to discover new drug targets (Phase-II)
Testing on disposable Biochips : A High Sensitivity Platform for Malaria Dectection
Development of Specific Inhibitor of Chikungunya Virus

Identification and characterization of differentially expressed host proteins for both S 27 and
DRDE – 06 strains of Chikungunya virus in mouse model : Implications in understanding its
epidemic potential
Development of 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino]
thiourea ( MBZM-N-IBT) as specific inhibitor of Chikungunya virus
Study on Persistence of Japanese encephalitis in reservoir host, pig in JE endemic area of
Odisha, Manipur and Assam
Nanomedicinal triple therapy with gemcitabine, hedgehog inhibitor and immune-stimulant : A
therapeutic boon for pancreatic cancer

Proteomic profiling of saliva and oral premalignant lesions by reverse-phase protein array to
identify potential diagnostic biomarkers
Investigating the role of a novel RING domain E-3-ubiquitin ligase, DZIP3 in regulation of cell
cycle and cancer progression
Toll like receptor (TLR) Polymorphisms and function: A clinical and experimental study in
dengue infection

Studies on Interactiom of Plant Transcription Factors in Full Length Transcript Promoter

Fragment of Plant Infecting Horse Radish Latent Virus ( HRLV )
"Structrual characterization of white spot …in nuclotide synthesis"
"DBT Programme for the NF project entited Development of seedless Bhimkol(Musa
balbisiana, BB genome) through CRISPR/Cas9 and mutation approaches"

DBT "Identification of Interacting ….Chikv ns p2 protein"

" Indo-UK Project entitled "The development and Implementation of Sensors and treatment
technologies for freshwater systems in India"
SERB "An Extracellular binding partner (ligand) to RAGE cytoplasmic tail in RAGE sigriding and
pathologies" of Dr. Vivek Rai".
"Bioresource and Sustainable livelihoods in North East India"
NA SI Enhancing Productivity
Identification and functional characterization of differentially expressed droght responsive
conserved .. …..Vigna unguiculata.
DST Project "Identification of major genetic and epigenetic components in the otosclerosis"

To Understand the role of FtsEX in coordinating the cell division with the membrane cleavage
in E.Coli
Role of Myocyte enhancer factor 2C ( MEF2C) IN Chronic myeloid leukemia
To Charcterize the exosomes secreted by chemotherapy-exposed pancreatic cancer associated
fibroblast cells ( CAFs) and investigate its role in chemoresistance of cancer cells

A study of the anti-cancerous activity present in Indian Horseshoe crab in breat bancer

Amino acid requirements in the sexual & liver stages of Malaria Parasite -An Immutable &
versatile target for malaria transmission.
Multi Instituional network programme on systemic lipus erythematous understanding the SLE

ILS-DBT-PJ-TELMI SARTAN-CHIKUN GUNYA-SOMA

siRNA targeted dual loaded mesoporous silica nanoparticles in orthotopic xenograft model of
lung cancer
Genetic Enhancement of Minor Pulses:Characterization,Evaluation, Genetic Enhancement and
Generation of Genomic Resources for Accelerated Utilization
and Improvement of Minor Pulses

Development of a vesicular stomatitis virus glycoprotein based virus-like nanoparticles

plateform for targeted drug delivery
Deciphering the role of TRIM family of protein in Neurodegeneartion and Neuroinflammation

Economic Empowerment of Tribes Farming Communication in one of the Aspirational Districts

of Odisha
A diagnostic panel for rapid detection of early-onset sepsis in high-risk neonates.
To understand the oscillation mechanism of the Min system and its role in coordinating cell
division with cell motility
Auxiliary Subunits of human SWI/SNF complex in normal myelopoiesis and leukemia

Financial Sanction under National Post-Doctoral Fellowship to Dr.Pradeepa , under the

mentorship of Dr.Soumen Chakraborty at ILS, BBSR

Financial Sanction under National Post-Doctoral Fellowship to Dr.Satyendra Kumar Singh,

under the mentorship of Dr. Vivek Rai at ILS, BBSR

Financial Sanction under National Post-Doctoral Fellowship to Dr.Trupti Mohapatra , under

the mentorship of Dr. Birendra Prasad Shaw at ILS, BBSR

Financial Sanction under National Post-Doctoral Fellowship to Dr.Aritreyee Datta , under the
mentorship of Dr. Dileep Vasudevan at ILS, BBSR

Financial Sanction under National Post-Doctoral Fellowship to Dr.K Vinothkumar , under the
mentorship of Dr. Soumen Chakraborty at ILS, BBSR

Financial Sanction under National Post-Doctoral Fellowship to Dr. Rashmirekha Pati , under
the mentorship of Dr. Sunil K Raghav at ILS, BBSR

Financial Sanction under National Post-Doctoral Fellowship to Dr.Shweta Thakur, under the
mentorship of Dr. Narottam Acharya at ILS, BBSR
Equipment Fellowship Meeting/Misc/Training Consumable Contingency Travel Overhead Interest incurred Scientific Social
& Workshop Resposibility

(92,100.00) (90,483.00) (138,093.00) 1,855,758.97 153,631.00 126,575.00

(23,313.00) (138,857.00) (48,136.00) 3,136.00

(71,816.00) (4,616.00) 65,630.68 50,000.00 17,491.00

(2,925.00) 4,667.00

10,763.00 (2,230.32) (599.00) 17,640.00 4,944.00

4,536.50 -

- 57,600.00 (7,506.63) 50,000.00 11,740.00

(21,678.00) (49,391.18) 5,208.00 69,066.00

(13,439.00) - 4,886.00 6,977.00 4,477.00

254,513.00 1,867.00 39.00 - 58,130.00

24,119.00

191,452.00 3,527.00 35,165.00 29,899.00

187,219.00 0.26 28,030.34 225,313.00 13,027.00

(23,612.00) (30,584.00) (10,350.00) 185,277.00 48,975.00

(112,760.00) 168,000.00 41,389.00 (117,156.00) 17,046.00

- (49,193.00) - (1,140,000.00) (17,451.00) (2,996.00) - 15,751.00

(8,067.16) 127,721.00 13,288.00

6,051.00 (15,000.00) 21,289.92 12,904.00

 (6,704.00) 17,289.00 3,512.00

- 132,594.00 - 36,662.00 100,000.00 50,508.00

10,237.00 2,385.00
4,409.92 - 4,305.00
(1,229,363.00) (162,881.00) (3,232,409.00) (197,601.00) (291,404.00) (208,032.00) 439,983.00

102,000.00 (6.16) 14,627.00

- (520,609.00) (3,690,000.00) (440,832.44) (42,844.00) 222,793.00

23,557.00 (44,600.00) 20,697.00 23,997.00 19,687.00

(18,215.00) - 18,215.00 - 40,677.00

(78,200.19) 102,328.00 (1,212.40) 16,286.00

- 5,470.00
83,216.00 487.00 10,333.00 16,490.00

13,617.58 231,467.00 6,331.00 5,094.00 44,520.00

(235,200.00) (4,835.00) 30,000.00 14,329.00

113,931.00 2,103.84 (39,891.00) 26,933.00

196,167.00 498.00 15,681.00 3,739.00

14,185.00 (30,314.00) 30,806.00 6,801.00

218,167.00 - 5,985.00 702.00 9,747.00

(110,000.00) 41,276.00 45,397.00 32,833.00

(159,840.00) 132,325.76 (25,313.00) 15,301.00

(7,240.12) 115,974.00 5,449.00 469.00 27,998.00

314,478.00 440,140.00 (150,153.58) 50,000.00 6,853.00

102,903.00 (1,244.00) 495.00 9,769.00

371,703.00 (56,407.96) 4,247.00 15,367.00

20,865.92 5,331.00 10,644.00

1,613,180.00 911,520.00 (51,328.48) 47,817.00 87,266.00

- 834,151.52 26,834.00

- (10.00) 14,709.00 - 12,556.00

 245,555.00 - 984.00 191,957.00 27,481.00

961,000.00 403,200.00 28,456.00 24,544.00 33,964.00

160,387.00 (49.00) 30,000.00 6,798.00

5,434.68 1,353.00

60,000.00 2,751.00 30,000.00 2,728.00

(9.24) 8,289.00

800,000.00 620,000.00 177,207.12 188,971.00 16,790.00

549,000.00 360,000.00 - 50,000.00 60,000.00

560,645.00 270,000.00 20,000.00 20,000.00 100,000.00

12,671,000.00 8,232,032.00 6,239,780.00 6,000,000.00 49,101.17 100,000.00 200,000.00 344,870.00

600,000.00 25,000.00 25,000.00 62,500.00

660,000.00 270,000.00 25,000.00 20,000.00 100,000.00

119,000.00 (2,282.00) (2,456.00) (10,200.00) 1,180.00

- -

660,000.00 200,000.00 100,000.00

56,833.00 (11,689.00)

259,032.00

58,667.00

56,833.00

56,833.00 184,200.00
15,480,355.27 14,413,171.00 6,518,514.00 (472,161.24) 2,411,532.29 1,374,118.00 361,908.00 2,077,312.00 -
NGS Study (Sequencing ) For Other Agencies Top-Up Overseas Allowance Transferable Fund Total Equipment Fellowship Meeting/ Consumable
Misc/Training &
Workshop

1,815,288.97

(207,170.00)

56,689.68
1,742.00

30,517.68

4,536.50

111,833.37 - - -

3,204.82

2,901.00

314,549.00 - -

24,119.00 300,000.00

260,043.00 458,715.00

453,589.60 -

169,706.00

(3,481.00)

1,200,000.00 6,111.00 360,000.00 1,000,000.00

132,941.84 -

25,244.92
 14,097.00

319,764.00
12,622.00
8,714.92 1,500,000.00
(434,902.00) 1,335,000.00 6,058,000.00 2,076,391.00 1,000,000.00

116,620.84

(180,829.00) 4,624,040.00 (28,281.44) 1,372,996.00

43,338.00 80,000.00

40,677.00

39,201.41 334,672.00 1,100,000.00

5,470.00
110,526.00

301,029.58

(195,706.00)

103,076.84

216,085.00

21,478.00

234,601.00

9,506.00

(37,526.24)

142,649.88 371,000.00 900,000.00

661,317.42 -

111,923.00

334,909.04

36,840.92

2,608,454.52
860,985.52

27,255.00
 465,977.00

1,451,164.00

197,136.00

6,787.68 700,000.00

95,479.00

8,279.76 615,000.00

1,802,968.12

1,019,000.00

970,645.00

33,836,783.17

712,500.00

1,075,000.00

- 528,000.00 2,500,000.00

105,242.00

- 684,000.00

- 50,000.00 485,000.00 1,200,000.00

960,000.00

45,144.00

259,032.00

58,667.00 660,000.00 200,000.00

56,833.00 660,000.00 200,000.00

241,033.00 660,000.00 200,000.00

- 660,000.00 200,000.00
 -
1,200,000.00 - (615,731.00) 1,335,000.00 10,682,040.00 54,766,058.32 50,000.00 5,098,672.00 - 13,830,711.00

54,766,058.32

-
Contingency Travel Overhead Interest incurred Scientific Social NGS Study For Other Agencies Top-Up Overseas Allowance Transferable Fund
Resposibility (Sequencing )

- - -

58.00

- - - 1,871.00

576,000.00

50,000.00 91,285.00

3,566.00

35,000.00 25,000.00 35,000.00 (15,751.00)

- - 1,837.00

329.00
 367.00

65,827.00 37,590.00 (3,573.00)

1,643,862.00

2,760,388.00

20,000.00

88,258.00 (3,332.00)

4,697.00

338.00

124.00

44,551.00 49,531.00 (27,998.00)

-
 -

50,000.00 50,000.00 63,000.00

50,000.00 35,000.00 68,000.00

200,000.00 200,000.00

64,000.00

40,000.00 30,000.00 142,000.00 10,000.00

50,000.00

50,000.00

50,000.00

100,000.00
1,199,636.00 427,121.00 733,285.00 (37,467.00) 10,000.00 - - - - 4,404,250.00

25,716,208.00

-
Total (A+B) Equipment Fellowship Meeting/ Consumable Contingency Travel
Misc/Training &
Workshop

- 1,815,288.97 250,000.00 1,573,850.00

- (207,170.00)

- 56,689.68
- 1,742.00

- 30,517.68 167,000.00

- 4,536.50

- 111,833.37 293,760.00 - -

- 3,204.82 196,000.00 2,820.00

58.00 2,959.00 -

1,871.00 316,420.00 - - -

876,000.00 900,119.00 100,000.00 49,155.00

600,000.00 860,043.00 72,000.00

- 453,589.60 - 156,194.00 - - 59,654.00

3,566.00 173,272.00 2,596.00

- (3,481.00) 90,000.00

1,439,249.00 1,445,360.00 149,000.00 - 5,000.00

1,837.00 134,778.84 - - -

329.00 25,573.92 12,000.00

 367.00 14,464.00

- 319,764.00 14,004.00 13,347.00

- 12,622.00
1,599,844.00 1,608,558.92 1,500,000.00 20,396.00
2,643,862.00 4,720,253.00 163,920.00 1,000,000.00 88,736.00 33,960.00

- 116,620.84 168,189.00 4,225.00

4,133,384.00 4,105,102.56 261,637.00 1,372,996.00 374,924.00 11,280.00

100,000.00 143,338.00 118,000.00

- 40,677.00

1,519,598.00 1,558,799.41 (78,200.00) 98,000.00

- 5,470.00
- 110,526.00 196,000.00 4,053.00

- 301,029.58 13,618.00 196,000.00 5,015.00

- (195,706.00)

- 103,076.84 96,000.00

4,697.00 220,782.00 70,968.00

338.00 21,816.00

- 234,601.00 220,000.00

124.00 9,630.00

- (37,526.24)

1,337,084.00 1,479,733.88 173,555.00 900,000.00 3,900.00

- 661,317.42 375,425.00 28,069.00

- 111,923.00 78,979.00

- 334,909.04 88,000.00

- 36,840.92 8,678.00

- 2,608,454.52 224,950.00 13,415.00 48,977.00

- 860,985.52 523,382.00 74,275.00

- 27,255.00 296,290.00
 - 465,977.00 110,871.00 9,869.00

- 1,451,164.00 2,832.00

- 197,136.00 70,000.00 8,942.00

863,000.00 869,787.68 700,000.00

- 95,479.00 2,080.00

768,000.00 776,279.76 615,000.00

- 1,802,968.12 161,200.00 7,032.00 36,159.00

- 1,019,000.00 16,000.00 23,672.00

- 970,645.00 275,000.00 270,000.00

- 33,836,783.17 708,893.00 19,800.00 1,240,846.00 47,842.00 529,026.00

- 712,500.00 600,000.00

- 1,075,000.00 275,000.00 270,000.00

3,428,000.00 3,428,000.00 51,549.00 - 480.00 27,830.00

- 105,242.00 85,000.00

748,000.00 748,000.00 680,000.00

1,957,000.00 1,957,000.00 1,200,000.00

- 960,000.00 220,000.00 200,000.00

- 45,144.00 56,833.00

- 259,032.00 259,032.00

910,000.00 968,667.00 275,000.00 200,000.00

910,000.00 966,833.00 275,000.00 200,000.00

910,000.00 1,151,033.00 275,000.00 584,200.00

960,000.00 960,000.00 228,871.00 200,000.00

 - -
25,716,208.00 80,482,266.32 (64,582.00) 7,207,691.00 395,225.00 12,328,424.00 2,240,431.00 895,662.00

80,482,266.32

-
Overhead Interest incurred Scientific Social NGS Study (Sequencing ) For Other Top-Up Overseas Transferable Total Equipment
Resposibility Agencies Allowance Fund

1,823,850.00 -92,100.00

- -

- -
- -

167,000.00 10,763.00

- -

293,760.00 -

198,820.00 -

- -

- - 254,513.00

149,155.00 -

91,285.00 163,285.00 -

215,848.00 -

2,596.00 -

90,000.00 -

35,000.00 651,360.00 840,360.00 -

- -

12,000.00 -
 - -

27,351.00 -
- -
1,520,396.00 -
90,000.00 13,550.00 1,390,166.00 -1,229,363.00

172,414.00 -

16,439.00 2,037,276.00 -

7,000.00 125,000.00 -

- -

19,800.00 -0.19
- -
200,053.00 -

214,633.00 -0.42

- -

96,000.00 -

70,968.00 -

- 14,185.00

220,000.00 -

- -

- -

1,077,455.00 -7,240.12

403,494.00 -

78,979.00 -

88,000.00 -

8,678.00 -

287,342.00 1,613,180.00
597,657.00 -

12,556.00 308,846.00 -
 27,481.00 148,221.00 -

2,832.00 961,000.00

78,942.00 -

63,000.00 763,000.00 -

2,080.00 -

68,000.00 683,000.00 -

204,391.00 800,000.00

39,672.00 549,000.00

100,000.00 645,000.00 -

2,546,407.00 12,671,000.00

62,500.00 662,500.00 -

100,000.00 645,000.00 -

79,859.00 -

85,000.00 -

64,000.00 744,000.00 -

1,200,000.00 50,000.00

100,000.00 520,000.00 -

56,833.00 -

259,032.00 -

50,000.00 525,000.00 -

50,000.00 525,000.00 -

50,000.00 909,200.00 -

100,000.00 528,871.00 -
 - -
1,030,785.00 40,037.00 - 651,360.00 - 29,989.00 - - 24,755,022.00 15,594,937.27

24,755,022.00
-
Fellowship Meeting/ Consumable Contingency Travel Overhead Interest incurred Scientific Social NGS Study (Sequencing For Other
Misc/Training & Resposibility ) Agencies
Workshop

-340,483.00 -138,093.00 - 281,908.97 153,631.00 - 126,575.00 - - -

- -23,313.00 - -138,857.00 -48,136.00 - 3,136.00 - - -

-71,816.00 - -4,616.00 65,630.68 50,000.00 - 17,491.00 - - -

- - - - -2,925.00 - 4,667.00 - - -

-167,000.00 - - -2,230.32 -599.00 17,640.00 4,944.00 - - -

- - 4,536.50 - - - - - - -

-236,160.00 - - -7,506.63 50,000.00 - 11,740.00 - - -

-217,678.00 - - -49,391.18 2,388.00 - 69,066.00 - - -

-13,439.00 - - 4,886.00 6,977.00 - 4,535.00 - - -

1,867.00 - - 39.00 - - 60,001.00 - - -

200,000.00 - - 550,964.00 - - - - - -

191,452.00 - 386,715.00 53,527.00 35,165.00 - 29,899.00 - - -

31,025.00 - 0.26 28,030.34 165,659.00 - 13,027.00 - - -

-23,612.00 - -30,584.00 -12,946.00 185,277.00 - 52,541.00 - - -

-202,760.00 - 168,000.00 41,389.00 -117,156.00 - 17,046.00 - - -

161,807.00 - -140,000.00 12,549.00 22,004.00 - - - 548,640.00 -

- - - -8,067.16 127,721.00 - 15,125.00 - - -

-5,949.00 - -15,000.00 21,289.92 - - 13,233.00 - - -

 - - - -6,704.00 17,289.00 - 3,879.00 - - -

132,594.00 - - 22,658.00 86,653.00 - 50,508.00 - - -

- - - - 10,237.00 - 2,385.00 - - -
- - - 70,236.92 17,194.00 - 732.00 - -
-326,801.00 - -3,232,409.00 -286,337.00 -325,364.00 -298,032.00 439,983.00 - - -

-66,189.00 - - -4,231.16 - - 14,627.00 - - -

-782,246.00 - -3,690,000.00 -815,756.44 -54,124.00 - 222,793.00 - - -

-14,443.00 - -44,600.00 20,697.00 23,997.00 13,000.00 19,687.00 - - -

-18,215.00 - - 18,215.00 - - 40,677.00 - - -

339,000.00 - 1,100,000.00 87,045.60 - - 12,954.00 - - -

- - - - 5,470.00 - - - - -
-112,784.00 - - -3,566.00 10,333.00 - 16,490.00 - - -

35,467.00 - - 1,316.00 5,094.00 - 44,520.00 - - -

-235,200.00 - - -4,835.00 30,000.00 - 14,329.00 - - -

17,931.00 - - 2,103.84 -39,891.00 - 26,933.00 - - -

125,199.00 - - 498.00 15,681.00 - 8,436.00 - - -

-30,314.00 - - - 30,806.00 - 7,139.00 - - -

-1,833.00 - - 5,985.00 702.00 - 9,747.00 - - -

-110,000.00 - - 41,276.00 45,397.00 - 32,957.00 - - -

-159,840.00 - - 132,325.76 -25,313.00 - 15,301.00 - - -

313,419.00 - - 46,100.00 50,000.00 - - - - -

314,478.00 64,715.00 - -150,153.58 21,931.00 - 6,853.00 - - -

23,924.00 - - -1,244.00 495.00 - 9,769.00 - - -

283,703.00 - - -56,407.96 4,247.00 - 15,367.00 - - -

- - - 12,187.92 5,331.00 - 10,644.00 - - -

686,570.00 - - -64,743.48 -1,160.00 - 87,266.00 - - -

- - -523,382.00 834,151.52 -74,275.00 - 26,834.00 - - -

-296,290.00 - - -10.00 14,709.00 - - - - -

 134,684.00 - - 984.00 182,088.00 - - - - -

403,200.00 - - 25,624.00 24,544.00 - 33,964.00 - - -

90,387.00 - - -8,991.00 30,000.00 - 6,798.00 - - -

- - - 55,434.68 50,000.00 - 1,353.00 - - -

60,000.00 - - 671.00 30,000.00 - 2,728.00 - - -

- - - 49,990.76 35,000.00 - 8,289.00 - - -

458,800.00 - - 170,175.12 152,812.00 - 16,790.00 - - -

344,000.00 - - 26,328.00 60,000.00 - - - - -

285,645.00 - - 20,000.00 20,000.00 - - - - -

7,523,139.00 6,219,980.00 4,759,154.00 1,259.17 -429,026.00 200,000.00 344,870.00 - - -

- - - 25,000.00 25,000.00 - - - - -

385,000.00 - - 25,000.00 20,000.00 - - - - -

476,451.00 - 2,500,000.00 199,520.00 172,170.00 - - - - -

34,000.00 - - -2,282.00 -2,456.00 -10,200.00 1,180.00 - - -

- - 4,000.00 - - - - - - -

485,000.00 - - 40,000.00 30,000.00 142,000.00 - 10,000.00 - -

440,000.00 - - - - - - - - -

- - -11,689.00 - - - - - - -

- - - - - - - - - -

443,667.00 - - - - - - - - -

441,833.00 - - - - - - - - -

441,833.00 - -200,000.00 - - - - - - -

431,129.00 - - - - - - - - -
 - - - - - - - - - -
12,304,152.00 6,123,289.00 1,030,125.76 1,370,737.29 905,577.00 64,408.00 1,999,808.00 10,000.00 548,640.00 -
Top-Up Overseas Allowance Transferable Fund Total

Updated on Remarks

- - - -8,561.03 As on 28-08-2019

- - - -207,170.00 As on 28-08-2019

- - - 56,689.68 As on 28-08-2019
- - - 1,742.00 As on 28-08-2019

- - - -136,482.32 As on 28-08-2020

- - - 4,536.50 As on 28-08-2021

- - - -181,926.63 As on 28-08-2019

- - - -195,615.18 As on 28-08-2019

PROJECT CLOSED IN F.Y - 19-20, BANK

- - - 2,959.00 Project closed in FY-19-20
AC NO. 17420 CLOSED

PROJECT CLOSED IN F.Y - 19-20, BANK

- - - 316,420.00 Project closed in FY-19-20
AC NO.17420 CLOSED ON 06-06-2019

- - - 750,964.00 As on 28-08-2019

- - - 696,758.00 As on 28-08-2019

- - - 237,741.60 As on 28-08-2019

PROJECT CLOSED in F.Y-19-20 & RS.

- - - 170,676.00 1,70,676/- refunded to DST on date. 07- Project closed in FY-19-20
08-2019

- - - -93,481.00 As on 28-08-2019

- - - 605,000.00 As on 28-08-2019

PROJECT CLOSED in F.Y-19-20 & RS.

- - - 134,778.84 1,34,778.84/- refunded to DBT on date. Project closed in FY-19-20
06.06.2019

PROJECT CLOSED in F.Y-19-20 & RS.

- - - 13,573.92 13,573.92 refunded to SERB on date. Project closed in FY-19-20
22.05.2019
 PROJECT CLOSED in F.Y-19-20 & RS.
- - - 14,464.00 14,464/- refunded to RGCB on date. 18- Project closed in FY-19-20
06-2019

- - - 292,413.00 As on 28-08-2019
- - - 12,622.00 As on 28-08-2019
- - - 88,162.92 As on 28-08-2019
-448,452.00 1,335,000.00 7,701,862.00 3,330,087.00

- - - -55,793.16 As on 28-08-2019

-197,268.00 - 7,384,428.00 2,067,826.56

- - - 18,338.00 As on 28-08-2019

- - - 40,677.00 As on 28-08-2019

- - - 1,538,999.41 As on 28-08-2019
- - - 5,470.00 As on 28-08-2019
- - - -89,527.00 As on 28-08-2019

- - - 86,396.58 As on 28-08-2019

- - - -195,706.00 As on 28-08-2019

- - - 7,076.84 As on 28-08-2019

Project Closed During the F Y- 2019-20

- - - 149,814.00 & Rs.1,49,814/- refunded to DST on Project closed in F.Y-19-20
date. 21-08-2019

Project Closed During the F Y- 2019-20

- - - 21,816.00 & Rs.21,816/- refunded to DBT on date. Project closed in F.Y-19-20
14-06-2019

- - - 14,601.00 As on 28-08-2019

Project Closed During the F Y- 2019-20

- - - 9,630.00 & Rs. 9,630/- refunded to SERB on date. Project closed in F.Y-19-20
17-05-2019

- - - -37,526.24 As on 28-08-2019

- - - 402,278.88 As on 28-08-2019
Molecular Taxonomy Workshop
- - - 257,823.42 As on 28-08-2019 amount is included in the
statement
- - - 32,944.00 As on 28-08-2019

- - - 246,909.04 As on 28-08-2019

- - - 28,162.92 As on 28-08-2019

- - - 2,321,112.52 As on 28-08-2019
- - - 263,328.52 As on 28-08-2019

- - - -281,591.00 As on 28-08-2019
- - - 317,756.00 As on 28-08-2019

- - - 1,448,332.00 As on 28-08-2019

- - - 118,194.00 AS on 28-08-2019

- - - 106,787.68 AS on 28-08-2019

- - - 93,399.00 AS on 28-08-2019

- - - 93,279.76 As on 28-08-2019

- - - 1,598,577.12 As on 28-08-2019

- - - 979,328.00 As on 28-08-2019

- - - 325,645.00 As on 28-08-2019

- - - 31,290,376.17 As on 28-08-2019

- - - 50,000.00 As on 28-08-2019

- - - 430,000.00 As on 28-08-2020

- - - 3,348,141.00 As on 28-08-2019

- - - 20,242.00 As on 28-08-2019

- - - 4,000.00 As on 28-08-2019

- - - 757,000.00 As on 28-08-2019

- - - 440,000.00 As on 31-08-2019 SERB-NPDF

- - - -11,689.00 As on 31-08-2019 SERB-NPDF

- - - - As on 31-08-2019 SERB-NPDF

- - - 443,667.00 As on 31-08-2019 SERB-NPDF

- - - 441,833.00 As on 31-08-2019 SERB-NPDF

- - - 241,833.00 As on 31-08-2019 SERB-NPDF

- - - 431,129.00 As on 31-08-2019 SERB-NPDF

 - - - -
(645,720.00) 1,335,000.00 15,086,290.00 55,727,244.32

-
55,727,244.32 55,727,244.32